October 2017 - Volume 23 - Issue 10 - Contributor Index

Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease

Tronstad, Rune R.; Kummen, Martin; Holm, Kristian; More

Inflammatory Bowel Diseases. 23(10):1752-1761, October 2017.

Author:
Barp, Jacopo MD

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study

Domènech, Eugeni; Garcia, Valle; Iborra, Marisa; More

Inflammatory Bowel Diseases. 23(10):1840-1846, October 2017.

Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohn's Disease

Feng, Ting; Chen, Baili; Li, Li; More

Inflammatory Bowel Diseases. 23(10):1817-1824, October 2017.

Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection

Bhandari, Sanjay; Mohammed Abdul, Mubeen Khan; Dhakal, Binod; More

Inflammatory Bowel Diseases. 23(10):1847-1852, October 2017.

IBD LIVE Series—Case 8: Treatment Options for Refractory Esophageal Crohn's Disease and Hidradenitis Suppurativa

Iskandar, Heba; Greer, Julia B.; Krasinskas, Alyssa M.; More

Inflammatory Bowel Diseases. 23(10):1667-1677, October 2017.

  • Video

Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study

Gold, Stephanie L.; Cohen-Mekelburg, Shirley; Schneider, Yecheskel; More

Inflammatory Bowel Diseases. 23(10):1882-1889, October 2017.

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

Guerbau, Loic; Gerard, Romain; Duveau, Nicolas; More

Inflammatory Bowel Diseases. 23(10):1853-1859, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

Guerbau, Loic; Gerard, Romain; Duveau, Nicolas; More

Inflammatory Bowel Diseases. 23(10):1853-1859, October 2017.

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

Broekman, Mark M. T. J.; Coenen, Marieke J. H.; van Marrewijk, Corine J.; More

Inflammatory Bowel Diseases. 23(10):1873-1881, October 2017.